Complete dosage information for 25N-NBOMe — threshold, light, common, strong, and heavy dose ranges across 1 route of administration.
Full 25N-NBOMe profileImportant Safety Notice
Dosage information is for harm reduction purposes only. Individual sensitivity varies greatly. Always start with the lowest effective dose and work your way up slowly. Never eyeball doses — use a milligram scale.
fatal in some cases. Although there are no reported deaths caused by 25N-NBOMe at this time,potentially fatal at heavy dosages. It is strongly recommended that one use harm reduction practices when using this drug. 25N-not habit-forming, and the desire to use it can actually decrease with use. It is most often self-regulating. Tolerance to the effects of 25N-almost immediately after ingestion. After that,37 days to be back at baseline (in the absence of further consumption). 25N-NBOMe presents cross-tolerance with Cross-all psychedelics, meaning that after the consumption of 25N-NBOMe all psychedelics will have a reduced effect. - Overdose - **Austria:** 25N-NBOMe is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich). - **Brazil:** Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344. - **Germany:** 25N-NBOMe is controlled under Anlage I BtMG (Narcotics Act, Schedule I) as of June 9, 2016. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license. - **Latvia:** 25N-NBOMe is a Schedule I controlled substance. - **Switzerland:** 25N-NBOMe is a controlled substance specifically named under Verzeichnis E. - **United Kingdom:** 25N-NBOMe is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause. - **United States:** 25N-NBOMe is unscheduled in the United States. It may be considered an analogue of 2C-N (which is a Schedule I drug under the Controlled Substances Act). As such, the sale for human consumption or the use for illicit non-medical or indus
A common sublingual dose of 25N-NBOMe is 300–800 µg.
The threshold dose for 25N-NBOMe via sublingual is approximately 100 µg.
25N-NBOMe typically lasts 5–10 hours via sublingual.